Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.000 | ||
| Révision: | $849.02M | $959.00M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.840 | 1.160 | 0.3200 |
| Révision: | $903.72M | $927.00M | $60.28M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.330 | 1.700 | 0.3700 |
| Révision: | $905.34M | $968.00M | -$8.34M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.000 | 1.140 | 0.1400 |
| Révision: | $950.84M | $912.00M | -$31.84M |
